Reading Time: < 1 minute
SABC News’ Luvuyo Mdeni is joined by the Principal Investigator of the South African Ox1Cov-19 Vaccine VIDA trial, Professor Shabir Madhi. In this episode, he gives an update on the trial which is under way at three sites in Gauteng.
Professor Madhi speaks at length on safety measures taken during the trial as well as when we can expect results:
